Alexander Abitbol

3.9k total citations
19 papers, 250 citations indexed

About

Alexander Abitbol is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Alexander Abitbol has authored 19 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 7 papers in Surgery. Recurrent topics in Alexander Abitbol's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (13 papers) and Diabetes and associated disorders (9 papers). Alexander Abitbol is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (13 papers) and Diabetes and associated disorders (9 papers). Alexander Abitbol collaborates with scholars based in Canada, Ireland and Argentina. Alexander Abitbol's co-authors include Ronnie Aronson, Ruth E. Brown, Ronald Goldenberg, Katherine S. Tweden, Hasnain Khandwala, Harpreet S. Bajaj, Antonio Ciaccia, Tom Elliott, Michael A. Tsoukas and Sorin Beca and has published in prestigious journals such as Diabetes, Cardiovascular Research and Diabetic Medicine.

In The Last Decade

Alexander Abitbol

18 papers receiving 240 citations

Peers

Countries citing papers authored by Alexander Abitbol

Since Specialization

Citations

This map shows the geographic impact of Alexander Abitbol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Abitbol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Abitbol more than expected).

Fields of papers citing papers by Alexander Abitbol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Abitbol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Abitbol. The network helps show where Alexander Abitbol may publish in the future.

Co-authorship network of co-authors of Alexander Abitbol

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Abitbol. A scholar is included among the top collaborators of Alexander Abitbol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Abitbol. Alexander Abitbol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study 2025 ·Diabetic Medicine ·(unknown), Alexander Abitbol	1
2	Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials 2025 ·Diabetes Obesity and Metabolism ·Ronnie Aronson, Alexander Abitbol, Harpreet S. Bajaj, Alice Cheng, Stavroula Christopoulos, Stewart B. Harris, (unknown), Ronald Goldenberg	1
3	What do the guidelines say about use of biosimilar insulin therapy? Simple practical considerations to guide clinicians in different patient subgroups—Sharing Canadian perspectives 2025 ·Diabetes Obesity and Metabolism ·Alexander Abitbol, (unknown)	1
4	Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study 2024 ·Diabetes Obesity and Metabolism ·(unknown), Ryan M. Bradley, Pernille Auerbach, Alexander Abitbol	4
5	AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D) 2022 ·Canadian Journal of Diabetes ·(unknown), Sanjit K. Bhogal, Peter Lin, Andrew Steele, (unknown), Antonio Ciaccia, Alexander Abitbol	14
6	Real‐world glycaemic outcomes in adult persons with type 1 diabetes using a real‐time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL‐CGM‐T1D) 2022 ·Diabetic Medicine ·Ruth E. Brown, (unknown), Gregory J. Norman, Alexander Abitbol	7
7	IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non‐insulin Antihyperglycaemic ThErapy ( IMMEDIATE ): A randomized controlled trial 2022 ·Diabetes Obesity and Metabolism ·Ronnie Aronson, Ruth E. Brown, (unknown), Harpreet S. Bajaj, Hasnain Khandwala, Alexander Abitbol, (unknown), Ronald Goldenberg	65
8	Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study 2021 ·Clinical Therapeutics ·(unknown), (unknown), (unknown), Antonio Ciaccia, Alexander Abitbol	22
9	The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study 2021 ·Diabetes and Vascular Disease Research ·Tom Elliott, Sorin Beca, (unknown), Michael A. Tsoukas, (unknown), Alexander Abitbol	31
10	The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 Diabetes 2020 ·Diabetes Technology & Therapeutics ·Ronnie Aronson, Ruth E. Brown, Alexander Abitbol, Ronald Goldenberg, Zeina Yared, Buki Ajala, Jean‐François Yale	19
11	Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study 2019 ·Canadian Journal of Diabetes ·Alexander Abitbol, Ruth E. Brown, (unknown), Luc Sauriol, Ronnie Aronson	13
12	Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study 2019 ·Diabetes Research and Clinical Practice ·Ruth E. Brown, Alexander Abitbol, Harpreet S. Bajaj, Ronald Goldenberg, Hasnain Khandwala, (unknown), Ronnie Aronson	10
13	First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes 2019 ·Diabetes Obesity and Metabolism ·Ronnie Aronson, Alexander Abitbol, Katherine S. Tweden	29
14	1679-P: Current State of Type 1 Diabetes in Adults: Data from the Canadian LMC Diabetes Registry 2019 ·Diabetes ·Ronnie Aronson, Ruth E. Brown, Alexander Abitbol, Ronald Goldenberg, Olubukola Ajala, Jean François Yale, Zeina Yared	1
15	Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial 2018 ·Diabetes Technology & Therapeutics ·Alexander Abitbol, Rémi Rabasa‐Lhoret, Virginie Messier, Laurent Legault, (unknown), Neale Cohen, Ahmad Haidar	28
16	Patient-Reported Outcomes following Initiation of Glucagon-Like Peptide-1 Receptor AgonistS (GLP–1RA) in PatientS with Type 2 Diabetes—PROGRESS-DIABETES Study 2018 ·Diabetes ·Ruth E. Brown, Alexander Abitbol, Harpreet S. Bajaj, Hasnain Khandwala, Ronald Goldenberg, (unknown), Ronnie Aronson	1
17	Advanced Self-Care Program: Preliminary Results from a 6-Month Intervention for Patients with Chronically Uncontrolled Diabetes 2017 ·Canadian Journal of Diabetes ·Alexander Abitbol, Ruth E. Brown, (unknown), (unknown), (unknown), Ronnie Aronson	1
18	Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness vs. Hypoglycemia Awareness: Randomized Controlled Trial 2016 ·Canadian Journal of Diabetes ·Rémi Rabasa‐Lhoret, Alexander Abitbol, Virginie Messier, Laurent Legault, (unknown), Martin Ladouceur, Ahmad Haidar	1
19	Phosphate-induced hypocalcaemia and experimental digitalis intoxication 1974 ·Cardiovascular Research ·Alexander Abitbol, (unknown), (unknown), (unknown), Cynthia Guzzo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact